Abvc Biopharma (ABVC) Change in Accrued Expenses (2009 - 2026)
Abvc Biopharma (ABVC) posted Change in Accrued Expenses of $208,945 for Q3 2026, compared with -$33,632 a year earlier and up 357.6% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Change in Accrued Expenses at Abvc Biopharma was $409,934, up 308.0% year-over-year; for FY2025, it was $152,207, down 0.4% from FY2024.
- Annual Change in Accrued Expenses has declined for three consecutive years.
- In prior years, Abvc Biopharma's Change in Accrued Expenses was $152,819 in FY2024 (-76.1%), $638,762 in FY2023 (-60.3%), $1.61 million in FY2022 and -$173,151 in FY2021.
- The Q3 2026 figure stands as the highest quarterly Change in Accrued Expenses since Q2 2023.
- According to Business Quant data, Change in Accrued Expenses for the three prior quarters was $45,663 (Q2 2026), -$7,265 (Q1 2026) and $162,591 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 208,945.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 208,945.00 |
| Jun 30, 2026 | 45,663.00 |
| Mar 31, 2026 | -7,265.00 |
| Dec 31, 2025 | 162,591.00 |
| Sep 30, 2025 | -33,632.00 |
| Jun 30, 2025 | -16,865.00 |
| Mar 31, 2025 | 40,113.00 |
| Dec 31, 2024 | 110,870.00 |
| Sep 30, 2024 | -39,949.00 |
| Jun 30, 2024 | 125,503.00 |
| Mar 31, 2024 | -43,605.00 |
| Dec 31, 2023 | -9,864.00 |
| Sep 30, 2023 | 116,848.00 |
| Jun 30, 2023 | 678,094.00 |
| Mar 31, 2023 | -146,316.00 |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | -77,391.00 |
| Jun 30, 2022 | 91,377.00 |
| Mar 31, 2022 | -113,292.00 |
| Dec 31, 2021 | 165,777.00 |
API Access
Abvc Biopharma Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();